Cytoskeletal remodeling in cancer

J Aseervatham - Biology, 2020 - mdpi.com
Simple Summary Cell migration is an essential process from embryogenesis to cell death.
This is tightly regulated by numerous proteins that help in proper functioning of the cell. In …

Cancer stem cell in breast cancer therapeutic resistance

X Bai, J Ni, J Beretov, P Graham, Y Li - Cancer treatment reviews, 2018 - Elsevier
Abstract Development of therapeutic resistance and metastasis is a major challenge with
current breast cancer (BC) therapy. Mounting evidence suggests that a subpopulation of …

Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines

Q Zhu, X Zhao, Y Zhang, Y Li, S Liu, J Han… - Nature …, 2023 - nature.com
Human cancer cell lines have long served as tools for cancer research and drug discovery,
but the presence and the source of intra-cell-line heterogeneity remain elusive. Here, we …

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

C Koch, A Kuske, SA Joosse, G Yigit… - EMBO molecular …, 2020 - embopress.org
Functional studies giving insight into the biology of circulating tumor cells (CTC s) remain
scarce due to the low frequency of CTC s and lack of appropriate models. Here, we describe …

Intermediate filaments at the junction of mechanotransduction, migration, and development

R Sanghvi-Shah, GF Weber - Frontiers in cell and developmental …, 2017 - frontiersin.org
Mechanically induced signal transduction has an essential role in development. Cells
actively transduce and respond to mechanical signals and their internal architecture must …

Intermediate filaments as effectors of cancer development and metastasis: a focus on keratins, vimentin, and nestin

P Sharma, S Alsharif, A Fallatah, BM Chung - Cells, 2019 - mdpi.com
Intermediate filament (IF) proteins make up the largest family of cytoskeletal proteins in
metazoans, and are traditionally known for their roles in fostering structural integrity in cells …

Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death

J Gisby, CL Clarke, N Medjeral-Thomas, TH Malik… - Elife, 2021 - elifesciences.org
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We
measured 436 circulating proteins in serial blood samples from hospitalised and non …

Comprehensive characterization of circular RNAs in~ 1000 human cancer cell lines

H Ruan, Y Xiang, J Ko, S Li, Y Jing, X Zhu, Y Ye… - Genome medicine, 2019 - Springer
Background Human cancer cell lines are fundamental models for cancer research and
therapeutic strategy development. However, there is no characterization of circular RNAs …

[HTML][HTML] CK19-positive hepatocellular carcinoma is a characteristic subtype

JY Zhuo, D Lu, WY Tan, SS Zheng, YQ Shen… - Journal of …, 2020 - ncbi.nlm.nih.gov
The heterogeneity of hepatocellular carcinoma (HCC) commonly leads to therapeutic failure
of HCC. Cytokeratin 19 (CK19) is well acknowledged as a biliary/progenitor cell marker and …

CD133 in breast cancer cells: more than a stem cell marker

F Brugnoli, S Grassilli, Y Al-Qassab… - Journal of …, 2019 - Wiley Online Library
Initially correlated with hematopoietic precursors, the surface expression of CD133 was also
found in epithelial and nonepithelial cells from adult tissues in which it has been associated …